The global clinical chemistry analyzers market is expected to reach USD 16.0 billion by 2025,
according to a new study by Grand View Research, Inc. The growing prevalence of
chronic diseases is anticipated to be responsible for the high urgency to adopt
clinical chemistry analyzers, which thereby widens the scope for growth during
the forecast period. In addition, growing base of geriatric and bariatric
population, which is highly susceptible to chronic diseases, is presumed to
impel the demand further. Consequently, the resultant high sample volume
requiring high capability analyzing devices is driving the market growth.
Moreover, increasing awareness pertaining
to benefits associated with these devices is also a high impact rendering
driver for clinical chemistry analyzers market. Advent of advanced chemistry
analyzers has resulted in improved point-of-care testing capabilities, and thus
created high potential growth opportunities for the market. In addition,
technological advancements in preanalytical, analytical, and post analytical
stages due to analyzing devices & reagents improved their diagnostic
capabilities and overall efficiency, which is predicted to propel the growth
further. These advancements include advent of microchips, sensors,
chemometrics, and robotics. Furthermore, consistent efforts by public as well
private healthcare organizations to increase the reliability of data have
rapidly engendered the integration of automated chemistry analyzers and
immunoassay systems, thereby resulting in overall reduction of workload in
laboratories, thus propelling the demand.
Full
Research Report On Clinical Chemistry Analyzers Market Analysis: http://www.grandviewresearch.com/industry-analysis/clinical-chemistry-analyzer-market
Further Key Findings From the Study Suggest:
·
Reagents held a substantial
share in product segment in 2015. The substantial share can be attributed to
increasing reagent rental agreements and availability resulting in quick global
access
·
Lipid panel is anticipated to
exhibit lucrative CAGR during the forecast period owing to increasing adoption,
as the demand for screening tests for cholesterol and triglyceride levels in
case of cardiovascular disorders and diabetes has increased
·
In 2016, North America
accounted for substantial share in the global clinical chemistry analyzers
market, as a consequence of local presence of prominent companies involved in
high R&D investments
·
Asia Pacific is anticipated to
grow at an exponential CAGR due to unmet patient needs, continuous
technological & infrastructural upgradation, and growing healthcare
expenditure
·
Some key participants such as
Mindray Medical International Ltd.; Johnson & Johnson; and F.Hoffmann-La
Roche Ltd. are undertaking various sustainability strategies, such as new
product development & frequent product approvals, to gain competitive
advantage
·
For instance, in August 2016,
Mindray announced the premarket FDA clearance for Mindray BA-800M clinical
chemistry analyzer allowing it to distribute its product
View More Reports Of This Category
By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
clinical chemistry analyzers market on the basis of product, test, end use, and
region:
Clinical Chemistry Analyzers Product Outlook (Revenue,
USD Million, 2014 - 2025)
·
Analyzers
o Small
o Medium
o Large
o Others
·
Reagents
o Calibrators
o Controls
o Standards
o Others
·
Others
Clinical Chemistry Analyzers Test Outlook (Revenue, USD
Million, 2014 - 2025)
·
Basic Metabolic Panel(BMP)
·
Electrolyte Panel
·
Liver Panel
·
Lipid Profile
·
Renal Profile
·
Thyroid Function Panel
·
Specialty Chemical Tests
Clinical Chemistry Analyzers End-Use Outlook (Revenue,
USD Million, 2014 - 2025)
·
Hospitals
·
Academic Research Centers
·
Diagnostic Laboratories
·
Others
Clinical Chemistry Analyzers Regional Outlook (Revenue,
USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o UK
o Germany
·
Asia Pacific
o Japan
o China
o India
·
Latin America
o Mexico
o Brazil
·
MEA
o South Africa
Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-clinical-chemistry-analyzers-market
https://www.grandviewresearch.com/press-release/global-clinical-chemistry-analyzers-market
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/
No comments:
Post a Comment